Arvinas (ARVN) Equity Income (2019 - 2023)
Arvinas (ARVN) recorded quarterly Equity Income of -$100000.0 in Q3 2023, up 92.31% quarter-over-quarter from -$1.3 million in Q2 2023, and up 96.55% on a YoY basis from -$50877.2 in Q3 2022.
Arvinas (ARVN) Equity Income (2019 - 2023) Analysis & Trends
Arvinas' Equity Income history runs 4 years deep, the most recent figure standing at -$100000.0 for Q3 2023.
- In Q3 2023, Equity Income rose 96.55% year-over-year to -$100000.0; the TTM figure through Jun 2024 stood at -$100000.0 (up 98.77% YoY), while the FY2023 annual figure was -$2.5 million, up 76.42% from the prior year.
- Equity Income was -$100000.0 for Q3 2023 at Arvinas, up from -$1.3 million in the prior quarter.
- In the past five years, Equity Income ranged from a high of -$25000.0 in Q4 2019 to a low of -$24.7 million in Q3 2019.
- Historically, Equity Income has averaged -$4.2 million across 4 years, with a median of -$2.4 million in 2022.
- The sharpest annual moves came in 2020 and 2023: Equity Income plunged 16300.0% in 2020, then jumped 96.55% in 2023.
- A 4-year view of Equity Income shows it stood at -$25000.0 in 2019, then slumped by 16300.0% to -$4.1 million in 2020, then jumped by 31.71% to -$2.8 million in 2022, then soared by 96.43% to -$100000.0 in 2023.
- The last three Equity Income figures came in at -$100000.0 (Q3 2023), -$1.3 million (Q2 2023), and -$1.1 million (Q1 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 235,807.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Arvinas | 492.16 Mn | -122.74 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | -100,000.00 |
| Jun 30, 2023 | -1.30 Mn |
| Mar 31, 2023 | -1.10 Mn |
| Dec 31, 2022 | -2.80 Mn |
| Sep 30, 2022 | -2.90 Mn |
| Jun 30, 2022 | -2.50 Mn |
| Mar 31, 2022 | -2.30 Mn |
| Dec 31, 2020 | -4.10 Mn |
| Dec 31, 2019 | -25,000.00 |
| Sep 30, 2019 | -24.68 Mn |